Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

Bristol-Myers Squibb (BMS) building

Opdivo to be tested as ‘double immunotherapy’ for tumours

BMS and Ono to test anti-PD-1 in combination with Kyowa Hakko's mogamulizumab

- PMLiVE

Merck to start major trial of Keytruda in breast cancer

PD-1 immunotherapy is already available as treatment for melanoma

- PMLiVE

Kim Lemon appointed head of Liberation Unlimited

Will lead rebrand of Communiqué award-winning agency

Paolo Casati named as general manager of Santen Italy

Has over 30 years of experience in the sector

- PMLiVE

Cello Health acquires market research firm Promedica

Move is the group’s second acquisition of the year

- PMLiVE

Alzheimer’s charity launches £20m trials fund

Aims to fast-track research into dementia treatments

- PMLiVE

Don’t forget email in your marketing strategy

Could it be the most underrated marketing channel in pharma?

Pfizer taps mobile app for patient recruitment

Looks to use smartphone technology to identify rare disease patients

- PMLiVE

UK Labour party pledges £330m cancer fund

Says will improve access to cancer drugs, radiotherapy and surgery if elected

- PMLiVE

ASH: Pfizer eyes re-launch of Mylotarg

Data supports drug's use in acute myeloid leukaemia

Eli Lilly HQ

Lilly reports first pivotal data for Xeljanz rival in arthritis

Baricitinib on course for regulatory filing in late 2015

- PMLiVE

Cancer care celebrated at awards

QiC Oncology programme recognises teams working to improve patient outcomes in oncology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links